BNTC - Company ID 0001808898
Benitec Biopharma Inc. (BNTC) reported net income of -$45.67M for fiscal year 2026, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2026 | -$45.67M | -20.4% |
| FY 2025 | -$37.92M | -74.3% |
| FY 2024 | -$21.75M | -11.2% |
| FY 2023 | -$19.56M | -7.4% |
| FY 2022 | -$18.21M | -31.2% |
| FY 2021 | -$13.88M | -67.8% |
| FY 2020 | -$8.27M | -417.1% |
| FY 2019 | $2.61M | - |
Benitec Biopharma Inc. (BNTC) reported net income of -$45.67M for fiscal year 2026, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2026, Benitec Biopharma Inc.'s net income declined from $2.61M to -$45.67M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.